Skip to main content
. 2011 Jun 28;17:1734–1744.

Table 5. Allele and genotype association analysis between the LOXL1 SNPs and different gender of XFS/XFG.

 
 
 
Genotype count (proportion)
Allele count (proportion)
Gender Group rs1048661 (n) TT GT GG χ2 p value G T χ2 p value OR (95%CI)
Male
XFS/XFG
41
1 (0.02)
14 (0.34)
26 (0.63)
4.08
0.130
66 (0.80)
16 (0.20)
3.92
0.048
1.90 (1.00–3.59)
 
Control
81
10 (0.12)
31 (0.38)
40 (0.49)
 
 
111 (0.69)
51 (0.31)
 
 
 
Female
XFS/XFG
23
1 (0.04)
6 (0.26)
16 (0.70)
4.98
0.083
38 (0.83)
8 (0.17)
2.32
0.128
1.97 (0.82–4.78)
 
Control
46
1 (0.02)
25 (0.54)
20 (0.43)
 
 
65 (0.71)
27 (0.29)
 
 
 
 
 
 
Genotype count (proportion)
Allele count (proportion)
Gender
Group
rs2165241 (n)
CC
CT
TT
χ2
p value
T
C
χ2
p value
OR (95%CI)
Male
XFS/XFG
41
12 (0.29)
19 (0.46)
10 (0.24)
9.45
0.009
39 (0.48)
43 (0.52)
10.8
0.001
2.51 (1.44–4.39)
 
Control
81
46 (0.57)
27 (0.33)
8 (0.10)
 
 
43 (0.27)
119 (0.73)
 
 
 
Female
XFS/XFG
23
2 (0.09)
9 (0.39)
12 (0.52)
27.6
0.000
33 (0.72)
13 (0.28)
34.1
0.000
9.75 (4.31–22.07)
 
Control
46
29 (0.63)
15 (0.33)
2 (0.04)
 
 
19 (0.21)
73 (0.79)
 
 
 
 
 
 
Genotype count (proportion)
Allele count (proportion)
Gender
Group
rs3825942 (n)
GG
GA
AA
χ2
p value
G
A
χ2
p value
OR (95%CI)
Male
XFS/XFG
41
36 (0.88)
5 (0.12)
0 (0.00)
8.41
0.015
77 (0.94)
5 (0.06)
7.89
0.005
3.79 (1.42–10.14)
 
Control
81
51 (0.63)
28 (0.35)
2 (0.02)
 
 
130 (0.80)
32 (0.20)
 
 
 
Female
XFS/XFG
23
22 (0.96)
1 (0.04)
0 (0.00)
8.46
0.004
45 (0.98)
1 (0.02)
7.19
0.007
10.2 (1.31–79.26)
  Control 46 29 (0.63) 17 (0.37) 0 (0.00)     75 (0.82) 17 (0.18)      

There were significant differences in allelic and genotypic proportion between the genders in the patient and control groups for the SNPs rs2165241 and rs3825942. T allele of rs2165241 and G of rs3825942 were risk alleles for the disorder for both the male and female groups. Total indicates the general test of association in the 2-by-3 table of disease-by-genotype.